JO
OYST

John Overdeck’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

John Overdeck’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-28,584
Closed -$826K – 3702
2020
Q2 		$826K Buy
+28,584
New +$861K ﹤0.01% 1655

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KXA
KPCB XIV Associates Menlo Park, California $42.8M AUM 16.52% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

John Overdeck's OYST Position: Q3 2020 in Review

John Overdeck sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q3 2020, closing a stake of 28,584 shares — an estimated $826K sold.

John Overdeck first reported a position in OYST in Q2 2020 and held it in 1 quarter. The position peaked at $826K in Q2 2020. 66 funds tracked by Wall St. Rank hold OYST as of Q3 2020.

  • John Overdeck reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • John Overdeck sold 28,584 Oyster Point Pharma, Inc. Common Stock shares in Q3 2020, an estimated $826K.
  • John Overdeck first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • John Overdeck's Oyster Point Pharma, Inc. Common Stock position peaked at $826K in Q2 2020.
  • 66 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q3 2020.

Based on Two Sigma Investments's 13F filing for Q3 2020, filed 16 Nov 2020.